Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 Varian Medical Systems Schedules Second Quarter FY2017 News Release And Conference Call March 28, 2017 Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016 March 30, 2017
Varian Medical Systems Schedules Second Quarter FY2017 News Release And Conference Call March 28, 2017
Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016 March 30, 2017
